Tel Aviv University University
InnoCan Pharma announced a collaboration with Tel Aviv University to instill CBD medicine through exosomes — or the small cell structures created when stem cells multiply. The unconventional method will utilize the exosomes as “homing missiles,” as they can uniquely target cell organs damaged by COVID-19. Researchers then believe CBD’s anti-inflammatory properties will repair the damaged cells through a synergistic effect.
Founded Date:
N/A
Headquarters:
Israel
Technology:
COVID Labs/Universities
Employee Number:
N/A
Industry:
COVID R&D
Number Of Exists:
N/A
Funding Status:
N/A
Investor Type:
N/A
Investment Stage:
N/A